European Journal of Medicinal Chemistry p. 225 - 233 (2014)
Update date:2022-08-15
Topics:
Basanagouda, Mahantesha
Jambagi, Vishwanath B.
Barigidad, Nivedita N.
Laxmeshwar, Sandeep S.
Devaru, Venkatesh
Narayanachar
A series of new iodinated-4-aryloxymethylcoumarins 6, 8 and 10 have been obtained from the reaction of various 4-bromomethylcoumarins 4 with 2-iodophenol 5, 3-iodophenol 7 and 4-iodophenol 9 respectively. All the title compounds were screened for anticancer activity against two cancer cell lines (MDA-MB human adenocarcinoma mammary gland and A-549 human lung carcinoma) and two mycobacterial strains (Mycobacterium tuberculosis H37 RV and Mycobacterium phlei). The SAR results indicate that nine compounds are potent, among these 10h and 10i having chlorine are most effective. This is the first report assigning in vitro anti-mycobacterial, anticancer and structure-activity relationship for this new class of iodinated-4-aryloxymethyl-coumarins.
View MoreJi'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Contact:+1-416-493-6870
Address:Toronto, Canada
Huludao Tianqi Shengye Chemical Co.,Ltd.
Contact:0086 429 2075777
Address:Area B,Shipbuilding Industry Park,Beigang District,Huludao City,Liaoning prov.,China
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Doi:10.1021/om00020a046
(1994)Doi:10.1021/jo00803a004
(1971)Doi:10.1016/j.ejmech.2017.08.034
(2017)Doi:10.1016/S0960-894X(97)00165-0
(1997)Doi:10.1016/j.ejmech.2020.112948
(2021)Doi:10.1016/S0022-328X(98)00404-5
(1998)